Gastrointestinal Cancers

Dispatch Bio Announces First Patient Dosed in Phase 1 Study of DISP-10, a Novel Investigational Immunotherapy, in Advanced Gastrointestinal (GI) Cancers - Business Wire [Visit Site | Read More]

Advancing antibody drug conjugates in gastrointestinal cancers - Nature [Visit Site | Read More]

ctDNA in Gastrointestinal Cancers: What the Evidence Shows - Oncodaily [Visit Site | Read More]